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Abstract
AIM: To classify changes over time in causes of lower 
gastrointestinal bleeding (LGIB) and to identify factors 
associated with changes in the incidence and chara-
cteristics of diverticular hemorrhage (DH).
METHODS: A total of 1803 patients underwent colono-
scopy for overt LGIB at our hospital from 1995 to 2013. 
Patients were divided into an early group (EG, 1995-2006, 
n  = 828) and a late group (LG, 2007-2013, n  = 975), 
and specific diseases were compared between groups. In 
addition, antithrombotic drug (ATD) use and nonsteroidal 
anti-inflammatory drug (NSAID) use were compared 
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Retrospective Study
between patients with and without DH. 
RESULTS: Older patients (≥ 70 years old) and those 
with colonic DH were more frequent in LG than in EG 
(P  < 0.01). Patients using ATDs as well as NSAIDs, 
male sex, obesity (body mass index ≥ 25 kg/m2), 
smoking, alcohol drinking, and arteriosclerotic diseases 
were more frequent in patients with DH than in those 
without. 
CONCLUSION: Incidence of colonic DH seems to incr-
ease with aging of the population, and factors involved 
include use of ATDs and NSAIDs, male sex, obesity, 
smoking, alcohol drinking, and arteriosclerotic disease. 
These factors are of value in handling DH patients.
Key words: Lower gastrointestinal bleeding; Colonic 
diverticular hemorrhage; Increase of incidence; Aging
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Core tip: Colonic diverticular hemorrhage (DH) is the most 
frequent cause of lower gastrointestinal bleeding. A rapid 
increase in the incidence of colonic DH has been seen 
with the aging population. One reason is the widespread 
adoption of antithrombotic drugs (ATDs) since the early 
2000s, based on guidelines to prevent ischemic heart 
disease and ischemic cerebrovascular disease. DH is more 
likely in patients who are older, are men, obesity, use 
nonsteroidal anti-inflammatory drugs or ATDs, and have 
hypertension and diabetes associated with arteriosclerotic 
disease. These factors are of value in handling DH patients.
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INTRODUCTION
Lower gastrointestinal bleeding (LGIB) is often diagnosed 
in patients with overt bleeding, positive results for 
fecal occult blood, abdominal symptoms, and anemia. 
Colonoscopy is often the first test performed as an 
approach to the diagnosis and treatment of LGIB. In the 
United States, endoscopy is recommended “in the early 
evaluation of severe acute LGIB”[1].
Use of oral antithrombotic drugs (ATDs) and non­
steroidal anti-inflammatory drugs (NSAIDs) is increasing 
with the aging of the population, and the number of 
patients with diseases causing LGIB is increasing[2,3]. In 
addition, the types of diseases being encountered are 
also changing. In particular, the prevalence of colonic 
diverticulum is increasing. The aging population in 
Japan, as in Western countries, is showing an increase 
in diverticulosis[4,5]. DH is also increasing in Japan. In 
fact, diverticular hemorrhage (DH) is now one of the 
most common causes of LGIB in Japan and Western 
countries[2,3,6].
The present study examined changes over time in 
diseases causing LGIB that are associated with aging. In 
particular, this study sought to identify factors associated 
with changes in the incidence and patient characteristics 
of colonic DH. 
MATERIALS AND METHODS
Among 42540 patients who underwent colonoscopy at 
our hospital during the 19­year period between January 
1995 and December 2013, this retrospective study 
included those who underwent colonoscopy for overt 
LGIB. Our hospital is one of the emergency hospitals in 
Chikushino city, Fukuoka, Japan.
Our hospital also diagnoses and treats a large number 
of patients with inflammatory bowel disease (IBD). 
Patients with IBD (ulcerative colitis, Crohn’s disease, 
Behçet’s disease, intestinal tuberculosis) were excluded 
because of differences from other diseases in terms of 
diagnosis and treatment. We also excluded patients who 
developed bleeding after endoscopic treatment (e.g., 
biopsy, polypectomy), or who experienced bleeding 
from the small bowel. As a result, this study included 
1803 patients, all of whom were Japanese. This study 
was approved by the institutional review board of Fuku­
oka University Chikushi Hospital (R15­024) and was 
conducted in accordance with the Declaration of Helsinki. 
Also, since this was a retrospective study, the need to 
obtain informed consent to participate in the study was 
waived by the review board. 
Factors evaluated included sex (male/female ratio) 
and age ≥ 70 years, Obesity [body mass index (BMI) 
≥ 25 kg/m2]. Patients were categorized into 2 groups 
according to the use of oral ATDs [antiplatelet drugs 
(n = 266)]: Low­dose aspirin, ticlopidine, clopidogrel, 
cilostazol, limaprost alfadex, ethyl icosapentate, 
dipyridamole, sarpogrelate hydrochloride, beraprost 
sodium, dilazep; or anticoagulants (n = 58): Warfarin 
and dabigatran: No ATDs; ≥ 1 oral ATDs. Use of NSAIDs 
(loxoprofen, diclofenac, ibuprofen, etodolac, meloxicam, 
or celecoxib) was also examined. Two­group comparisons 
included the use or non-use of NSAIDs and the use or 
non-use of NSAIDs in combination with an antithrombotic 
drug. 
Two­group comparisons for lifestyle factors included 
smoking or non­smoking and use or non­use of alcohol. We 
treated current and past smoking as positive for smoking, 
while only current drinkers were defined as positive 
for alcohol. Other factors examined other underlying 
diseases (cerebrovascular disease, ischemic heart 
disease, hypertension, hyperlipidemia, hyperuricemia, 
diabetes mellitus, chronic liver disease, and chronic 
kidney disease). Comorbidity was quantified using the 
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Charlson Risk Index (CRI)[7]. Two groups were compared: 
CRI ≤ 1; and CRI ≥ 2. Transfusion requiring ≥ 2 units 
of blood was also examined as a factor. 
Diagnosis
Colonoscopy was generally performed on the day of or 
the day after overt bleeding. Depending on the clinical 
symptoms and physical examination findings in each 
patient, colonoscopy was performed without pretreatment, 
or after pretreatment with an enema or bowel­cleansing 
agent. Olympus colonoscopes were used (PCF­240AZI, 
PCF­240AI, CF­240AZI, CF­240ZI, PCF­260AZI, PCF­
PQ260I, and CF­260AI; Olympus, Tokyo, Japan). Colonic 
DH was defined as follows[8]. 
Definite colonic DH (n = 207): (1) Active bleeding 
observed from a diverticulum; and (2) Presence of blood 
clots, erosions, or an exposed vessel near a diverticulum.
Either (1) or (2), absence of blood in the terminal 
ileum on total colonoscopy, and no other obvious cause 
of bleeding.
Suspected colonic DH (n = 66): Obvious bloody 
stools, no blood in the terminal ileum on colonoscopy 
after bowel preparation, and the only likely cause of 
bleeding is DH.
Diseases causing LGIB were classified into hemo­
rrhoids, ischemic colitis, DH, advanced colon cancer, 
early colon cancer/polyps/adenomas, infectious enteritis, 
angiodysplasia, drug­related enteritis, and no abnormal 
findings. Rectal ulcers, stercoral ulcers, rectal mucosal 
prolapse, pneumatosis cystoides intestinalis, enteric 
endometriosis, submucosal tumors, radiation enteritis, and 
nonspecific inflammation were categorized as “Others”. 
Study period
The 1803 patients who underwent colonoscopy for overt 
LGIB were divided into two groups by time period, with 
each consisting of about half of the patients. The early 
group (EG, n = 828) was treated from January 1995 
to December 2006, and the late group (LG, n = 975) 
was treated from January 2007 to December 2013. 
Incidence of each disease during these two periods was 
compared. 
Statistical analysis
All statistical analyses were conducted using the Statistical 
Analysis System package (SAS Institute, Cary, NC). The 
χ 2 test was used to compare categorical variables between 
the two groups. Values of P < 0.05 were considered 
statistically significant.
RESULTS
Colonoscopy
A total of 1803 patients underwent colonoscopy for overt 
LGIB at our hospital between 1995 and 2013. Table 1 
summarizes the patient characteristics. Figure 1 shows 
the number of patients who underwent colonoscopy for 
overt LGIB each year, required hospitalization, required 
transfusions, and used oral ATDs and NSAIDs. The 
number of patients with overt LGIB tended to increase 
each year.
Comparison of specific diseases in EG and LG
Table 2 summarizes the specific diseases in the 1803 
patients who underwent colonoscopy for overt LGIB. 
In EG, the most common cause of overt LGIB was 
hemorrhoids in 212 patients (25.6%), followed by 
ischemic colitis in 143 patients (17.3%), advanced cancer 
in 80 patients (9.7%), early cancer/adenomas/polyps in 
53 patients (6.4%), and colonic DH in 49 patients (5.9%). 
In LG, the most common cause of overt LGIB was colonic 
DH in 224 patients (23.0%), followed by hemorrhoids 
in 220 patients (22.6%), ischemic colitis in 173 patients 
(17.7%), advanced cancer in 73 patients (7.5%), and 
early cancer/adenomas/polyps in 58 patients (5.9%). 
Compared with LG, EG showed lower frequencies of 
patients ≥ 70 years old (P < 0.01) and bleeding from 
colonic diverticulum (P < 0.01). The number of patients 
with DH tended to increase each year, with a marked 
increase after 2003 (Figure 2).
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Table 1  Baseline characteristics of all patients undergoing 
colonoscopy for overt lower gastrointestinal bleeding
Age, sex and other factors Overall n  = 1803 n  (%)
Sex
  Male   913 (50.6)
  Female   890 (49.4)
Age, yr
  Mean 59.0 ± 18.6
  ≥ 70   582 (32.3)
  < 70 1221 (67.7)
BMI, kg/m2 
  < 18.5   212 (11.8)
  18.5 to < 25 1049 (58.2)
  ≥ 25   337 (18.7)
  Unknown   205 (11.4)
Oral drugs
  ATDs   308 (17.1)
  NSAIDs 115 (6.4)
  ATDs + NSAIDs   26 (1.4)
Lifestyle habits
  Smoking (current/past)   551 (30.6)
  Alcohol drinking (current) 625 (34.7)
Underlying disease
  Cerebrovascular disease 171 (9.5)
  Ischemic heart disease 143 (7.9)
  Hypertension   658 (36.5)
  Hyperlipidemia   355 (19.7)
  Hyperuricemia   91 (5.0)
  Diabetes   207 (11.5)
  Chronic liver disease 106 (5.9)
  Chronic kidney disease   43 (2.4)
Charlson Risk Index
  ≤ 1 1413 (78.4)
  ≥ 2   390 (21.6)
Blood transfusion 130 (7.2)
Each set of values represents mean ± SD or n (%). BMI: Body mass index; 
ATDs: Antithrombotic drugs; NSAIDs: Nonsteroidal anti-inflammatory 
drugs. 
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widely used for risk reduction and secondary prevention 
of cerebral and cardiovascular events in Japan, based 
on 2002­2009 guidelines from the American College of 
Cardiology and American Heart Association[10,11]. ATDs and 
NSAIDs have been reported as risk factors for LGIB[2,3]. 
These background factors, together with the aging of the 
population, are thought to be key reasons for the rapid 
increase in the incidence of LGIB.
In particular, the incidence of colonic DH increased 
markedly from 5.9% in EG to 23.0% in LG, with a 
pronounced change in the specific diseases causing 
LGIB. In LG, colonic DH was the most common disorder 
causing LGIB. Moreover, colonic DH has also recently 
been reported as the most common cause of LGIB in 
Japan[2,12]. Compared to a few decades ago, changes 
in the aging­associated diseases that cause LGIB have 
been occurring. In particular, the incidence of colonic DH 
has increased.
Colonic diverticulosis itself is increasing. During the 
period from 1960 to the 1980s, Kubo et al[13] reported 
that the prevalence of colonic diverticula was only 
8.9% among patients who underwent barium enema 
examination. Since the 1990s, the prevalence of div­
erticulosis seen on barium enema examination or 
colonoscopy has increased to 15%­25%[5,14]. In addition, 
more than 80% of patients who had diverticulosis were 
elderly. Diverticulosis is thus thought to increase with 
aging[5]. As the absolute number of diverticula in colonic 
diverticulosis increases with the aging of the population, 
the risk of DH is increased. Moreover, as mentioned 
previously, the availability of low­dose aspirin has 
probably also contributed to the rapid rise in DH starting 
in 2001.  
Of course, bleeding does not occur in all patients with 
diverticulosis. In fact, bleeding only occurs in 2%­5% of 
Comparison of patient characteristics between DH and 
non-DH patients
As shown in Table 3, compared with non­DH, DH showed 
higher frequencies of patients ≥ 70 years old (P < 0.01) 
and male patients (P < 0.01). Seventy­nine (28.9%) 
of the 273 DH patients and 229 (15.0%) of the 1530 
non­DH patients received ATDs. ATDs were thus more 
commonly used in DH patients than in non­DH patients (P 
< 0.01). Thirty (11.0%) of the 273 DH patients and 85 
(5.6%) of the 1530 non-DH patients took oral NSAIDs. 
Oral NSAIDs were thus also more commonly used in DH 
patients than in non­DH patients (P < 0.01).
In addition, obesity (P < 0.01), smoking (P < 0.01), 
alcohol drinking (P < 0.01), hypertension (P < 0.01), 
hyperlipidemia (P = 0.02), diabetes (P < 0.01), and 
requirement for blood transfusion (P < 0.01) were 
significantly more frequent in DH patients than in non-DH 
patients.
DISCUSSION
The incidence of LGIB increased from 20.5/100000 
inhabitants/year in the early 1990s[6] to 87/100000 
inhabitants/year in 2010[3]. In particular, the incidence of 
LGIB is high in elderly patients (690/100000 inhabitants/
year)[3], and is expected to continue increasing with the 
aging of the population in Japan. The aging rate (≥ 65 
years old) of Japan was 12% in 1990, 20% in 2005. 
However, the aging rate of 2013 is higher than 25%, 
and aging advances[9]. Our study also showed an annual 
increase in the number of patients undergoing colonoscopy 
for overt LGIB. One background factor was the approval 
of low­dose aspirin 100 mg in Japan as an antiplatelet 
drug in 2000, with initial marketing in 2001. In addition, 
ATDs such as clopidogrel and warfarin became more 
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Figure 1  Annual totals and changes over time in number of patients 
undergoing colonoscopy for overt lower gastrointestinal bleeding, requiring 
hospitalization, requiring transfusions, and using antithrombotic drugs 
and nonsteroidal anti-inflammatory drugs (1995 to 2013). The incidence of 
lower gastrointestinal bleeding (LGIB) started to increase rapidly in 2002-2003, 
associated with increases in the number of patients hospitalized, receiving blood 
transfusions, using antithrombotic drugs (ATDs), and using nonsteroidal anti-
inflammatory drugs (NSAIDs).
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Figure 2 Changes in the number of patients with colonic diverticular 
hemorrhage: Number of patients requiring hospitalization, requiring 
transfusion, and using antithrombotic drugs or nonsteroidal anti-
inflammatory drugs (1995 to 2013). The number of patients with diverticular 
hemorrhage (DH) started to increase rapidly in 2003, and peaked in 2008. This 
was associated with an increase in the number of patients hospitalized, receiving 
blood transfusions, using antithrombotic drugs (ATDs), and using nonsteroidal 
anti-inflammatory drugs (NSAIDs).
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related to the association between older age, obesity, 
smoking, and alcohol drinking with arteriosclerotic disease.
Colonic diverticula develop at sites where the vasa 
recta penetrate the large intestinal wall when intestinal 
pressure increases. Blood vessels in the diverticula are 
separated from the bowel lumen only by the mucosa, 
and are easily injured. With repeated mechanical sti­
muli, intimal thickening of the vasa recta occurs, often 
with thinning of the media. These changes can cause 
segmental weakening of the vasa recta, which may lead 
to arterial hemorrhage in the bowel lumen[19]. Thus, 
because DH represents a form of arterial bleeding, trans­
fusion may be required more often than with bleeding 
due to other disorders.
Arteriosclerosis also plays a role in the pathogenesis 
patients during the natural history of diverticulosis, and 
most cases are relatively mild, resolving spontaneously 
in 75%­93% of cases[15,16].
In a case­control study in Japan, risk factors for DH 
included the use of ATDs and NSAIDs, hypertension, 
diabetes, arteriosclerotic diseases such as ischemic 
disease mellitus and chronic kidney disease, age ≥ 70 
years, obesity[13,15,17,18]. Our study also found higher 
rates of use for both ATDs and NSAIDs, higher age 
and male sex, obesity, smoking, alcohol drinking, and 
arteriosclerotic diseases in patients with colonic DH 
compared to those with bleeding from other causes. 
ATDs and NSAIDs thus represent risk factors for bleeding 
in diverticulosis. Moreover, higher rates of DH in patients 
who are older, obesity, smoke, or drink alcohol may be 
Table 2  Comparison between early group and late group among patients undergoing colonoscopy for overt lower gastrointestinal 
bleeding from 1995-2013 n  (%)
Age, sex and cause/site of bleeding All patients (1995-2013) 
n  = 1803
EG (1995-2006) 
n  = 828
LG (2007-2013) 
n  = 975
P-value Adjusted P -value
Old age (≥ 70 yr)   582 (32.3)   196 (23.7)   386 (39.6) < 0.01 < 0.01
Male   913 (50.6)   419 (56.0)   495 (50.8)    0.94    0.94
External/internal hemorrhoids   432 (24.0)   212 (25.6)   220 (22.6)    0.13    0.46
Ischemic colitis   316 (17.5)   143 (17.3)   173 (17.7)    0.79  0.1
Colonic DH   273 (15.1)   49 (5.9)   224 (23.0) < 0.01 < 0.01
Advanced colonic cancer 153 (8.5)   80 (9.7)   73 (7.5)   0.1    0.06
Early colon cancer/colon adenomas/polyps 111 (6.2)   53 (6.4)   58 (5.9)    0.69    0.73
Infectious enteritis   68 (3.8)   37 (4.5)   31 (3.2)    0.15  0.4
Angiodysplasia   27 (1.5)   15 (1.8)   12 (1.2)    0.31    0.26
Drug-related enteritis   23 (1.3)   13 (1.6)   10 (1.0)   0.3    0.32
Others   248 (13.8)   137 (16.5)   111 (11.4) - -
No abnormal findings 152 (8.4)     89 (10.7)   63 (6.5) - -
Total 1803 (100) 828 (100)  975 (100) - -
Adjusted P-value age- and sex-adjusted P-value; No abnormal findings no site identified as origin of bleeding; Each set of values represents number (%). χ 2 
test. EG: Early group: 1995-2006; LG: Late group: 2007-2013; DH: Diverticular hemorrhage. 
Table 3  Comparison of old age, sex, and use of antithrombotic drugs or nonsteroidal anti-inflammatory drugs between patients with 
and without diverticular hemorrhage n  (%)
DH (n  = 273) Non-DH (n  = 1530) Adjusted P  value
Old age (≥ 70 yr) 136 (49.8)   446 (29.2) < 0.01
Male sex 172 (63.0)   741 (48.4) < 0.01
Obesity (BMI ≥ 25 kg/m2)   82 (30.0)   255 (16.7) < 0.01
ATDs   79 (28.9)   229 (15.0) < 0.01
NSAIDs   30 (11.0)   85 (5.6) < 0.01
Smoking (current/past) 124 (45.4)   427 (27.9) < 0.01
Alcohol drinking (current) 139 (50.9)   486 (31.8) < 0.01
Cerebrovascular disease   36 (13.2) 134 (8.8)    0.67
Ischemic heart disease   34 (12.5) 109 (7.1)    0.33
Hypertension 178 (65.2)   480 (31.4) < 0.01
Hyperlipidemia   74 (27.1)   281 (18.4) < 0.05
Hyperuricemia 20 (7.3)   71 (4.6)    0.78
Diabetes   44 (16.1)   163 (10.7) < 0.01
Chronic liver disease 13 (4.8)   93 (6.1)  0.1
Chronic kidney disease   8 (2.9)   35 (2.3)    0.94
Charlson Risk Index ≥ 2   79 (28.9)     311 (20.3z)    0.67
Blood transfusion   56 (20.5)   74 (4.8) < 0.01
P value age- and sex-adjusted P-value; χ 2 test: Each set of values represents n (%). DH: Diverticular hemorrhage; ATDs: Antithrombotic drugs; NSAIDs: 
Nonsteroidal anti-inflammatory drugs; BMI: body mass index. 
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the translation to English. 
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mind when treating patients with LGIB.
Terminology
NSAIDs and ATDs have synergistic effects on injury to blood vessels in 
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leading to rupture of blood vessels in diverticula[20]. How­
ever, not all patients with diverticulosis experience 
bleeding; indeed, most patients remain asymptomatic. 
Therefore, in addition to arteriosclerosis, other factors 
increase the fragility of blood vessels in diverticula.
Our study was performed with adjustment for 
factors including sex and age, so analysis was performed 
independently of arteriosclerosis. The results identified 
NSAIDs and ATDs as a significant risk factor, suggesting 
that NSAIDs and ATDs have synergistic effects on injury 
to blood vessels in diverticula. Most NSAIDs inhibit 
prostaglandin synthesis, which disrupts the microcirculation 
and inhibits platelet aggregation. As a result, NSAIDs 
can lead to bleeding in patients with diverticulosis[17]. DH 
in Japan is more common in men, whereas in Western 
countries, DH occurs equally in men and women[21]. These 
findings suggest ethnic differences, but the exact factors 
involved are not yet well understood. DH in Japan is more 
common in men, because it may be one of the reasons 
the men listed as the risk of arteriosclerosis in the Japan 
Atherosclerosis Society Guidelines[22].
Our study examined patients who underwent colon­
oscopy for LGIB over a 19­year period, including detailed 
information about underlying diseases and medications, 
and found an increase in overt LGIB during this time. 
The investigation included a relatively large cohort of 273 
patients with colonic DH for comparison and analysis. We 
compared the baseline data of DH patients and those 
of non­DH patients among all subjects in this cohort. 
Therefore, there may have been little recall bias or 
selection bias in our study. We divided it in 2004 when we 
divided it for the same period or in 2000 when low­dose 
aspirin was approved as division of EG and LG. However, 
number of cases included a difference too much in EG and 
LG and was inappropriate for analysis. Thus, the 1803 
patients were divided into two groups by time period, with 
each consisting of about half of the patients.
However, some limitations to the study must be 
considered. One was the retrospective nature of the 
study design, and the fact that only a single institution 
was involved. In addition, this was not a strictly controlled 
study, as no comparison with non­bleeding diverticulosis 
was conducted. We had not evaluated by carotid artery 
ultrasonography for arteriosclerosis in this study.
In conclusion, a rapid increase in the incidence of 
colonic DH has been seen with the aging population. 
One reason is the widespread adoption of ATDs since the 
early 2000s, based on guidelines to prevent ischemic 
heart disease and ischemic cerebrovascular disease. 
Colonic DH is the most frequent cause of LGIB. 
DH is more likely in patients who are older, are men, 
obesity, use NSAIDs or ATDs, and have hypertension and 
diabetes associated with arteriosclerotic disease. These 
patients are also likely to have more severe anemia and 
require blood transfusions. These factors should be kept 
in mind when treating patients with LGIB.
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